Skip to main content
. 2020 Apr 20;15:2583–2603. doi: 10.2147/IJN.S231062

Figure 7.

Figure 7

The anti-growth effect after the treatment with varying doses of Fe3O4/SiO2/APTS (a); Fe3O4/SiO2/APTS~Schiff base (b); Fe3O4/SiO2/APTS~ Schiff base-Cu(II) (c) on K562 cell lines (myelogenous leukemia cancer) by the MTT as described in the experimental section. Data were normalized as a percentage of values of the control (*p<0.05 and **p<0.01).